Accordingly, in vitro studies have shown that tumor-derived TGFβ is able to induce activation of human prostate stroma through heavy deregulation of key signalling pathways crucially involved in maintaining tumor-promoting features, including FGF2, CTGF, SDF1, WNT3A and IGF axes [6, 7]. This evidence concerns the gene CXCL12 and neoplasm.